Document:

Lithium Exploration Group,Inc.: Exhibit 10.157 - Filed by newsfilecorp.com

SECURITIES PURCHASE AGREEMENT 

This SECURITIES PURCHASE AGREEMENT (the “Agreement”),
dated as of March 22, 2018, by and between Lithium Exploration Group, Inc.,
a Nevada corporation, with headquarters located at 4635 S. Lakeshore Dr. Ste
200, Tempe, AZ 85282, (the “Company”), and BlueCiti, LLC, A New York limited
liability company with its executive offices located at 1357 Ave Ashford, San
Juan, PR 00907 (the “Buyer). 

WHEREAS:

A.      The Company and the Buyer are
executing and delivering this Agreement in reliance upon the exemption from
securities registration afforded by the rules and regulations as promulgated by
the United States Securities and Exchange Commission (the “SEC”) under the
Securities Act of 1933, as amended (the “1933 Act”);

B.      Buyer desires to purchase and
the Company desires to issue and sell, upon the terms and conditions set forth
in this Agreement a 10% convertible note of the Company, in the form attached
hereto as Exhibit A in the aggregate principal amount of $20,000.00 which shall
contain a $2,000.00 OID such that the issuance price shall be $22,000.00 plus
interest and penalties if any become due and payable on March 22, 2020,
convertible into shares of common stock, $0.001 par value per share, of the
Company (the “Common Stock”), upon the terms and subject to the limitations and
conditions set forth in such Note.

C.      The Buyer wishes to purchase,
upon the terms and conditions stated in this Agreement, such principal amount of
Note as is set forth immediately below its name on the signature pages hereto;
and

NOW THEREFORE, the Company and the Buyer severally (and
not jointly) hereby agree as follows:

1.      Purchase and Sale of
Note. 

a.      Purchase of Note. On
the Closing Date (as defined below), the Company shall issue and sell to the
Buyer and the Buyer agrees to purchase from the Company such principal amount of
the Note as is set forth immediately below the Buyer’s name on the signature
pages hereto. 

_____ 
Company Initials 

b.      Form of Payment. On the
Closing Date (as defined below), the (A) Buyer shall (i) pay the purchase price
for the Note to be issued and sold to it at the Closing (as defined below) (the
“Purchase Price”) by wire transfer of immediately available funds to the
Company, in accordance with the Company’s written wiring instructions, against
delivery of the Note in the principal amount equal to the Purchase Price as is
set forth immediately below the Buyer’s name on the signature pages hereto and
(B) the Company shall deliver such duly executed Note on behalf of the Company,
to the Buyer, against delivery of such Purchase Price and Buyer Note.

c.      Closing Date. The date
and time of the first issuance and sale of the Note pursuant to this Agreement
(the “Closing Date”) shall be on or about March 22, 2018, or such other mutually
agreed upon time.

2.      Buyer’s Representations and
Warranties. The Buyer represents and warrants to the Company that:

a.      Investment Purpose. As
of the date hereof, the Buyer is purchasing the Note and the shares of Common
Stock issuable upon conversion of or otherwise pursuant to the Note, such shares
of Common Stock being collectively referred to herein as the “Conversion Shares”
and, collectively with the Note, the “Securities”) for its own account and not
with a present view towards the public sale or distribution thereof, except
pursuant to sales registered or exempted from registration under the 1933 Act;
provided, however, that by making the representations herein, the
Buyer does not agree to hold any of the Securities for any minimum or other
specific term and reserves the right to dispose of the Securities at any time in
accordance with or pursuant to a registration statement or an exemption under
the 1933 Act. 

b.      Accredited Investor
Status. The Buyer is an “accredited investor” as that term is defined in
Rule 501(a) of Regulation D (an “Accredited Investor”). 

c.      Reliance on Exemptions.
The Buyer understands that the Securities are being offered and sold to it in
reliance upon specific exemptions from the registration requirements of United
States federal and state securities laws and that the Company is relying upon
the truth and accuracy of, and the Buyer’s compliance with, the representations,
warranties, agreements, acknowledgments and understandings of the Buyer set
forth herein in order to determine the availability of such exemptions and the
eligibility of the Buyer to acquire the Securities. 

d.      Information. The Buyer
and its advisors, if any, have been, and for so long as the Note remain
outstanding will continue to be, furnished with all materials relating to the
business, finances and operations of the Company and materials relating to the
offer and sale of the Securities which have been requested by the Buyer or its
advisors. The Buyer and its advisors, if any, have been, and for so long as the
Note remain outstanding will continue to be, afforded the opportunity to ask
questions of the Company.Notwithstanding the foregoing, the Company has not disclosed to
the Buyer any material nonpublic information and will not disclose such
information unless such information is disclosed to the public prior to or
promptly following such disclosure to the Buyer. Neither such inquiries nor any
other due diligence investigation conducted by Buyer or any of its advisors or
representatives shall modify, amend or affect Buyer’s right to rely on the
Company’s representations and warranties contained in Section 3 below. The Buyer
understands that its investment in the Securities involves a significant degree
of risk. The Buyer is not aware of any facts that may constitute a breach of any
of the Company's representations and warranties made herein. 

2 

e.      Governmental Review.
  The Buyer understands that no United States federal or state agency or any other
  government or governmental agency has passed upon or made any recommendation or
endorsement of the Securities. 

f.      Transfer or Re-sale.
The Buyer understands that (i) the sale or re-sale of the Securities has not
been and is not being registered under the 1933 Act or any applicable state
securities laws, and the Securities may not be transferred unless (a) the
Securities are sold pursuant to an effective registration statement under the
1933 Act, (b) the Buyer shall have delivered to the Company, at the cost of the
Buyer, an opinion of counsel that shall be in form, substance and scope
customary for opinions of counsel in comparable transactions to the effect that
the Securities to be sold or transferred may be sold or transferred pursuant to
an exemption from such registration, which opinion shall be accepted by the
Company, (c) the Securities are sold or transferred to an “affiliate” (as
defined in Rule 144 promulgated under the 1933 Act (or a successor rule) (“Rule
144”)) of the Buyer who agrees to sell or otherwise transfer the Securities only
in accordance with this Section 2(f) and who is an Accredited Investor, (d) the
Securities are sold pursuant to Rule 144, or (e) the Securities are sold
pursuant to Regulation S under the 1933 Act (or a successor rule) (“Regulation
S”), and the Buyer shall have delivered to the Company, at the cost of the
Buyer, an opinion of counsel that shall be in form, substance and scope
customary for opinions of counsel in corporate transactions, which opinion shall
be accepted by the Company; (ii) any sale of such Securities made in reliance on
Rule 144 may be made only in accordance with the terms of said Rule and further,
if said Rule is not applicable, any re-sale of such Securities under
circumstances in which the seller (or the person through whom the sale is made)
may be deemed to be an underwriter (as that term is defined in the 1933 Act) may
require compliance with some other exemption under the 1933 Act or the rules and
regulations of the SEC thereunder; and (iii) neither the Company nor any other
person is under any obligation to register such Securities under the 1933 Act or
any state securities laws or to comply with the terms and conditions of any
exemption thereunder (in each case). Notwithstanding the foregoing or anything
else contained herein to the contrary, the Securities may be pledged as
collateral in connection with a bona fide margin account or other
lending arrangement.

g.      Legends. The Buyer
understands that the Note and, until such time as the Conversion Shares have
been registered under the 1933 Act may be sold pursuant to Rule 144 or
Regulation S without any restriction as to the number of securities as of a particular date that can then be immediately sold, the
Conversion Shares may bear a restrictive legend in substantially the following
form (and a stop-transfer order may be placed against transfer of the
certificates for such Securities):

3 

“NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED
  BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE
  EXERCISABLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED,
  OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE,
  SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE
  REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT OF 1933, AS
  AMENDED, OR (B) AN OPINION OF COUNSEL (WHICH COUNSEL SHALL BE SELECTED BY THE
  HOLDER), IN A GENERALLY ACCEPTABLE FORM, THAT REGISTRATION IS NOT REQUIRED UNDER
  SAID ACT OR (II) UNLESS SOLD PURSUANT TO RULE 144 OR RULE 144A UNDER SAID ACT.
  NOTWITHSTANDING THE FOREGOING, THE SECURITIES MAY BE PLEDGED IN CONNECTION WITH
  A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN OR FINANCING ARRANGEMENT SECURED BY THE
SECURITIES.” 

The legend set forth above shall be removed and the Company
shall issue a certificate without such legend to the holder of any Security upon
which it is stamped, if, unless otherwise required by applicable state
securities laws, (a) such Security is registered for sale under an effective
registration statement filed under the 1933 Act or otherwise may be sold
pursuant to Rule 144 or Regulation S without any restriction as to the number of
securities as of a particular date that can then be immediately sold, or (b)
such holder provides the Company with an opinion of counsel, in form, substance
and scope customary for opinions of counsel in comparable transactions, to the
effect that a public sale or transfer of such Security may be made without
registration under the 1933 Act, which opinion shall be accepted by the Company
so that the sale or transfer is effected. The Buyer agrees to sell all
Securities, including those represented by a certificate(s) from which the
legend has been removed, in compliance with applicable prospectus delivery
requirements, if any. In the event that the Company does not accept the opinion
of counsel provided by the Buyer with respect to the transfer of Securities
pursuant to an exemption from registration, such as Rule 144 or Regulation S,
within 2 business days, it will be considered an Event of Default under the
Note. 

h.      Authorization;
Enforcement. This Agreement has been duly and validly authorized. This
Agreement has been duly executed and delivered on behalf of the Buyer, and this
Agreement constitutes a valid and binding agreement of the Buyer enforceable in
accordance with its terms. 

i.      Residency. The Buyer is
a resident of the jurisdiction set forth immediately below the Buyer’s name on
the signature pages hereto.

4 

3.      Representations and
Warranties of the Company. The Company represents and warrants to the Buyer
that:\

a.      Organization and
Qualification. The Company and each of its subsidiaries, if any, is a
corporation duly organized, validly existing and in good standing under the laws
of the jurisdiction in which it is incorporated, with full power and authority
(corporate and other) to own, lease, use and operate its properties and to carry
on its business as and where now owned, leased, used, operated and conducted.

b.      Authorization; Enforcement. (i) The Company has all requisite
  corporate power and authority to enter into and perform this Agreement, the Note
  and to consummate the transactions contemplated hereby and thereby and to issue
  the Securities, in accordance with the terms hereof and thereof, (ii) the
  execution and delivery of this Agreement, the Note by the Company and the
  consummation by it of the transactions contemplated hereby and thereby
  (including without limitation, the issuance of the Note and the issuance and
  reservation for issuance of the Conversion Shares issuable upon conversion or
  exercise thereof) have been duly authorized by the Company’s Board of Directors
  and no further consent or authorization of the Company, its Board of Directors,
  or its shareholders is required, (iii) this Agreement has been duly executed and
  delivered by the Company by its authorized representative, and such authorized
  representative is the true and official representative with authority to sign
  this Agreement and the other documents executed in connection herewith and bind
  the Company accordingly, and (iv) this Agreement constitutes, and upon execution
  and delivery by the Company of the Note, each of such instruments will
  constitute, a legal, valid and binding obligation of the Company enforceable
  against the Company in accordance with its terms. 

c.      Issuance of Shares. The
Conversion Shares are duly authorized and reserved for issuance and, upon
conversion of the Note in accordance with its respective terms, will be validly
issued, fully paid and non-assessable, and free from all taxes, liens, claims
and encumbrances with respect to the issue thereof and shall not be subject to
preemptive rights or other similar rights of shareholders of the Company and
will not impose personal liability upon the holder thereof. 

d.      Acknowledgment of
Dilution. The Company understands and acknowledges the potentially dilutive
effect to the Common Stock upon the issuance of the Conversion Shares upon
conversion of the Note. The Company further acknowledges that its obligation to
issue Conversion Shares upon conversion of the Note in accordance with this
Agreement, the Note is absolute and unconditional regardless of the dilutive
effect that such issuance may have on the ownership interests of other
shareholders of the Company. 

e.      No Conflicts. The
execution, delivery and performance of this Agreement, the Note by the Company
and the consummation by the Company of the transactions contemplated hereby and
thereby (including, without limitation, the issuance and reservation for issuance of the Conversion Shares) will not
(i) conflict with or result in a violation of any provision of the Certificate
of Incorporation or By-laws, or (ii) violate or conflict with, or result in a
breach of any provision of, or constitute a default (or an event which with
notice or lapse of time or both could become a default) under, or give to others
any rights of termination, amendment, acceleration or cancellation of, any
agreement, indenture, patent, patent license or instrument to which the Company
or any of its subsidiaries is a party, or (iii) result in a violation of any
law, rule, regulation, order, judgment or decree (including federal and state
securities laws and regulations and regulations of any self-regulatory
organizations to which the Company or its securities are subject) applicable to
the Company or any of its subsidiaries or by which any property or asset of the
Company or any of its subsidiaries is bound or affected (except for such
conflicts, defaults, terminations, amendments, accelerations, cancellations and
violations as would not, individually or in the aggregate, have a material
adverse effect). All consents, authorizations, orders, filings and registrations
which the Company is required to obtain pursuant to the preceding sentence have
been obtained or effected on or prior to the date hereof. The Company is not in
violation of the listing requirements of the Over-the-Counter Quotations Bureau
(the “OTCQB”) and does not reasonably anticipate that the Common Stock will be
delisted by the OTCQB in the foreseeable future, nor are the Company’s
securities “chilled” by FINRA. The Company and its subsidiaries are unaware of
any facts or circumstances, which might give rise to any of the foregoing.

5 

f.      Absence of Litigation.
  Except as disclosed in the Company’s public filings, there is no action, suit,
  claim, proceeding, inquiry or investigation before or by any court, public
  board, government agency, self-regulatory organization or body pending or, to
  the knowledge of the Company or any of its subsidiaries, threatened against or
  affecting the Company or any of its subsidiaries, or their officers or directors
  in their capacity as such, that could have a material adverse effect. Schedule
  3(f) contains a complete list and summary description of any pending or, to the
  knowledge of the Company, threatened proceeding against or affecting the Company
  or any of its subsidiaries, without regard to whether it would have a material
  adverse effect. The Company and its subsidiaries are unaware of any facts or
circumstances, which might give rise to any of the foregoing. 

g.      Acknowledgment Regarding
Buyer’ Purchase of Securities. The Company acknowledges and agrees that the
Buyer is acting solely in the capacity of arm’s length purchasers with respect
to this Agreement and the transactions contemplated hereby. The Company further
acknowledges that the Buyer is not acting as a financial advisor or fiduciary of
the Company (or in any similar capacity) with respect to this Agreement and the
transactions contemplated hereby and any statement made by the Buyer or any of
its respective representatives or agents in connection with this Agreement and
the transactions contemplated hereby is not advice or a recommendation and is
merely incidental to the Buyer’ purchase of the Securities. The Company further
represents to the Buyer that the Company’s decision to enter into this Agreement
has been based solely on the independent evaluation of the Company and its
representatives. 

6 

h.      No Integrated Offering.
Neither the Company, nor any of its affiliates, nor any person acting on its or
their behalf, has directly or indirectly made any offers or sales in any
security or solicited any offers to buy any security under circumstances that
would require registration under the 1933 Act of the issuance of the Securities
to the Buyer. The issuance of the Securities to the Buyer will not be integrated
with any other issuance of the Company’s securities (past, current or future)
for purposes of any shareholder approval provisions applicable to the Company or
its securities. 

i.      Title to Property. The
Company and its subsidiaries have good and marketable title in fee simple to all
real property and good and marketable title to all personal property owned by
them which is material to the business of the Company and its subsidiaries, in
each case free and clear of all liens, encumbrances and defects except such as
are described in Schedule 3(i) or such as would not have a material adverse
effect. Any real property and facilities held under lease by the Company and its
subsidiaries are held by them under valid, subsisting and enforceable leases
with such exceptions as would not have a material adverse effect. 

j.      Bad Actor. No officer
or director of the Company would be disqualified under Rule 506(d) of the
Securities Act as amended on the basis of being a "bad actor" as that term is
established in the September 19, 2013 Small Entity Compliance Guide published by
the Securities and Exchange Commission. 

k.      Breach of Representations
and Warranties by the Company. If the Company breaches any of the
representations or warranties set forth in this Section 3, and in addition to
any other remedies available to the Buyer pursuant to this Agreement, it will be
considered an Event of default under the Note. 

4.      COVENANTS. 

a.      Listing. The Company
shall promptly secure the listing of the Conversion Shares upon each national
securities exchange or automated quotation system, if any, upon which shares of
Common Stock are then listed (subject to official notice of issuance) and, so
long as the Buyer owns any of the Securities, shall maintain, so long as any
other shares of Common Stock shall be so listed, such listing of all Conversion
Shares from time to time issuable upon conversion of the Note. The Company will
obtain and, so long as the Buyer owns any of the Securities, maintain the
listing and trading of its Common Stock on the OTCQB, OTC Pink, or any
equivalent replacement exchange, the Nasdaq National Market (“Nasdaq”), the
Nasdaq SmallCap Market (“Nasdaq SmallCap”), the New York Stock Exchange
(“NYSE”), or the American Stock Exchange (“AMEX”) and will comply in all
respects with the Company’s reporting, filing and other obligations under the
bylaws or rules of the Financial Industry Regulatory Authority (“FINRA”) and
such exchanges, as applicable. The Company shall promptly provide to the Buyer
copies of any notices it receives from the OTCQB, OTC Pink, and any other
exchanges or quotation systems on which the Common Stock is then listed
regarding the continued eligibility of the Common Stock for listing on such
exchanges and quotation systems. 

7 

b.      Corporate Existence. So
  long as the Buyer beneficially owns any Note, the Company shall maintain its
  corporate existence and shall not sell all or substantially all of the Company’s
  assets, except in the event of a merger or consolidation or sale of all or
  substantially all of the Company’s assets, where the surviving or successor
  entity in such transaction (i) assumes the Company’s obligations hereunder and
  under the agreements and instruments entered into in connection herewith and
  (ii) is a publicly traded corporation whose Common Stock is listed for trading
on the OTC Pink, OTCQB, Nasdaq, Nasdaq SmallCap, NYSE or AMEX. 

c.      No Integration. The
Company shall not make any offers or sales of any security (other than the
Securities) under circumstances that would require registration of the
Securities being offered or sold hereunder under the 1933 Act or cause the
offering of the Securities to be integrated with any other offering of
securities by the Company for the purpose of any stockholder approval provision
applicable to the Company or its securities. 

d.      Registration Rights.
With respect to any Company issued note owned by the Buyer, in the event the
Company completes a registration statement for its securities prior to the date
on which that particular note is eligible for conversion into legend free shares
under Rule 144, the shares issuable upon conversion of that particular note
shall be “piggybacked” onto the registration statement. 

e.      Breach of Covenants. If
the Company breaches any of the covenants set forth in this Section 4, and in
addition to any other remedies available to the Buyer pursuant to this
Agreement, it will be considered an event of default under the Note. 

5.      Governing Law;
Miscellaneous. 

a.      Governing Law. This
Agreement shall be governed by and construed in accordance with the laws of the
State of New York without regard to principles of conflicts of laws. Any action
brought by either party against the other concerning the transactions
contemplated by this Agreement shall be brought only in the state courts of New
York or in the federal courts located in the state and county of New York. The
parties to this Agreement hereby irrevocably waive any objection to jurisdiction
and venue of any action instituted hereunder and shall not assert any defense
based on lack of jurisdiction or venue or based upon forum non
conveniens. The Company and Buyer waive trial by jury. The prevailing party
shall be entitled to recover from the other party its reasonable attorney's fees
and costs. In the event that any provision of this Agreement or any other
agreement delivered in connection herewith is invalid or unenforceable under
any applicable statute or rule of law, then such provision
shall be deemed inoperative to the extent that it may conflict therewith and
shall be deemed modified to conform with such statute or rule of law. Any such
provision, which may prove invalid or unenforceable under any law, shall not
affect the validity or enforceability of any other provision of any agreement.
Each party hereby irrevocably waives personal service of process and consents to
process being served in any suit, action or proceeding in connection with this
Agreement or any other Transaction Document by mailing a copy thereof via
registered or certified mail or overnight delivery (with evidence of delivery)
to such party at the address in effect for notices to it under this Agreement
and agrees that such service shall constitute good and sufficient service of
process and notice thereof. Nothing contained herein shall be deemed to limit in
any way any right to serve process in any other manner permitted by law. 

8 

b.      Counterparts; Signatures by
  Facsimile. This Agreement may be executed in one or more counterparts, each
  of which shall be deemed an original but all of which shall constitute one and
  the same agreement and shall become effective when counterparts have been signed
  by each party and delivered to the other party. This Agreement, once executed by
  a party, may be delivered to the other party hereto by facsimile transmission of
  a copy of this Agreement bearing the signature of the party so delivering this
Agreement. 

c.      Headings. The headings
of this Agreement are for convenience of reference only and shall not form part
of, or affect the interpretation of, this Agreement. 

d.      Severability. In the
event that any provision of this Agreement is invalid or unenforceable under any
applicable statute or rule of law, then such provision shall be deemed
inoperative to the extent that it may conflict therewith and shall be deemed
modified to conform with such statute or rule of law. Any provision hereof which
may prove invalid or unenforceable under any law shall not affect the validity
or enforceability of any other provision hereof. 

e.      Entire Agreement;
Amendments. This Agreement and the instruments referenced herein contain the
entire understanding of the parties with respect to the matters covered herein
and therein and, except as specifically set forth herein or therein, neither the
Company nor the Buyer makes any representation, warranty, covenant or
undertaking with respect to such matters. No provision of this Agreement may be
waived or amended other than by an instrument in writing signed by the majority
in interest of the Buyer. 

f.      Notices. All notices,
demands, requests, consents, approvals, and other communications required or
permitted hereunder shall be in writing and, unless otherwise specified herein,
shall be (i) personally served, (ii) deposited in the mail, registered or
certified, return receipt requested, postage prepaid, (iii) delivered by
reputable air courier service with charges prepaid, or (iv) transmitted by hand
delivery, telegram, or facsimile, addressed as set forth below or to such other
address as such party shall have specified most recently by written notice. Any
notice or other communication required or permitted to be given hereunder shall
be deemed effective (a) upon hand delivery or delivery by facsimile, with
accurate confirmation generated by the transmitting facsimile machine, at the
address or number designated below (if delivered on a business day during normal
business hours where such notice is to be received), or the first business day
following such delivery (if delivered other than on a business day during normal
business hours where such notice is to be received) or (b) on the second
business day following the date of mailing by express courier service, fully
prepaid, addressed to such address, or upon actual receipt of such mailing,
whichever shall first occur. The addresses for such communications shall be:

9 

	 	If to the Company, to: 
	 	 	  
	 	 	Lithium Exploration Group, Inc. 
	 	 	3800 North Central Avenue, Suite 820 
	 	 	Phoenix, AZ 85012 
	 	 	Attn: Alex Walsh- CEO 
	 	 	  
	 	 	  
	 	If to the Buyer: 
	 	 	  
	 	 	BlueCiti, LLC 
	 	 	1357 Ave Ashford, 
	 	 	San Juan, PR 00907 
	 	 	Attn: Manager 

Each party shall provide notice to the other party of any
change in address. 

g.      Successors and Assigns.
This Agreement shall be binding upon and inure to the benefit of the parties and
their successors and assigns. Neither the Company nor the Buyer shall assign
this Agreement or any rights or obligations hereunder without the prior written
consent of the other. Notwithstanding the foregoing, the Buyer may assign its
rights hereunder to any person that purchases Securities in a private
transaction from the Buyer or to any of its “affiliates,” as that term is
defined under the 1934 Act, without the consent of the Company. 

h.      Third Party
Beneficiaries. This Agreement is intended for the benefit of the parties
hereto and their respective permitted successors and assigns, and is not for the
benefit of, nor may any provision hereof be enforced by, any other person. 

i.      Survival. The
representations and warranties of the Company and the agreements and covenants
set forth in this Agreement shall survive the closing hereunder notwithstanding
any due diligence investigation conducted by or on behalf of the Buyer. The Company agrees to indemnify and hold harmless
the Buyer and all their officers, directors, employees and agents for loss or
damage arising as a result of or related to any breach or alleged breach by the
Company of any of its representations, warranties and covenants set forth in
this Agreement or any of its covenants and obligations under this Agreement,
including advancement of expenses as they are incurred. 

10 

j.      Further Assurances.
  Each party shall do and perform, or cause to be done and performed, all such
  further acts and things, and shall execute and deliver all such other
  agreements, certificates, instruments and documents, as the other party may
  reasonably request in order to carry out the intent and accomplish the purposes
  of this Agreement and the consummation of the transactions contemplated hereby.

k.      No Strict Construction.
The language used in this Agreement will be deemed to be the language chosen by
the parties to express their mutual intent, and no rules of strict construction
will be applied against any party. 

l.      Remedies. The Company
acknowledges that a breach by it of its obligations hereunder will cause
irreparable harm to the Buyer by vitiating the intent and purpose of the
transaction contemplated hereby. Accordingly, the Company acknowledges that the
remedy at law for a breach of its obligations under this Agreement will be
inadequate and agrees, in the event of a breach or threatened breach by the
Company of the provisions of this Agreement, that the Buyer shall be entitled,
in addition to all other available remedies at law or in equity, and in addition
to the penalties assessable herein, to an injunction or injunctions restraining,
preventing or curing any breach of this Agreement and to enforce specifically
the terms and provisions hereof, without the necessity of showing economic loss
and without any bond or other security being required. 

IN WITNESS WHEREOF, the undersigned Buyer and the Company have
caused this Agreement to be duly executed as of the date first above written.

	Lithium Exploration Group, Inc. 
	  	 
	  	 
	  	
	By: 	 
	Name: Alex Walsh 
	Title: CEO 
	  	 
	  	 
	BlueCiti, LLC. 
	  	 
	By: 	 
	Name: Manager 

11 

	AGGREGATE SUBSCRIPTION AMOUNT: 	  
	 	 
	Aggregate Principal Amount of Note: 	$27,500.00 
	 	 
	$2,500 in OID, attached as Exhibit A, hereto 	  

     EXHIBIT A 
144 NOTE -
$27,500 

12 

13Lithium Exploration Group, Inc.: Exhibit 10.158 - Filed by newsfilecorp.com

SECURITIES PURCHASE AGREEMENT 

This SECURITIES PURCHASE AGREEMENT (the “Agreement”),
dated as of March 22, 2018, by and between Lithium Exploration Group, Inc.,
a Nevada corporation, with headquarters located at 4635 S. Lakeshore Dr. Ste
200, Tempe, AZ 85282, (the “Company”), and BlueCiti, LLC, A New York limited
liability company with its executive offices located at 1357 Ave Ashford, San
Juan, PR 00907 (the “Buyer). 

WHEREAS:

A.     The Company and the Buyer are executing and
delivering this Agreement in reliance upon the exemption from securities
registration afforded by the rules and regulations as promulgated by the United
States Securities and Exchange Commission (the “SEC”) under the Securities Act
of 1933, as amended (the “1933 Act”);

B.     Buyer desires to purchase and the Company desires to
issue and sell, upon the terms and conditions set forth in this Agreement a 10%
convertible note of the Company, in the form attached hereto as Exhibit A in the
aggregate principal amount of $20,000.00 which shall contain a $2,000.00 OID
such that the issuance price shall be $22,000.00 plus interest and penalties if
any become due and payable on March 22, 2020, convertible into shares of common
stock, $0.001 par value per share, of the Company (the “Common Stock”), upon the
terms and subject to the limitations and conditions set forth in such Note.

C.     The Buyer wishes to purchase, upon the terms and
conditions stated in this Agreement, such principal amount of Note as is set
forth immediately below its name on the signature pages hereto; and

 NOW
THEREFORE, the Company and the Buyer severally (and not jointly) hereby
agree as follows:

1.     Purchase and Sale of Note.

 a.     Purchase of Note. On the Closing Date (as
  defined below), the Company shall issue and sell to the Buyer and the Buyer
  agrees to purchase from the Company such principal amount of the Note as is set
forth immediately below the Buyer’s name on the signature pages hereto. 

________
Company Initials 

b.     Form of Payment. On the Closing Date (as
defined below), the (A) Buyer shall (i) pay the purchase price for the Note to
be issued and sold to it at the Closing (as defined below) (the “Purchase
Price”) by wire transfer of immediately available funds to the Company, in
accordance with the Company’s written wiring instructions, against delivery of
the Note in the principal amount equal to the Purchase Price as is set forth
immediately below the Buyer’s name on the signature pages hereto and (B) the
Company shall deliver such duly executed Note on behalf of the Company, to the
Buyer, against delivery of such Purchase Price and Buyer Note.

  c.     Closing Date. The date and time of the first
  issuance and sale of the Note pursuant to this Agreement (the “Closing Date”)
  shall be on or about March 22, 2018, or such other mutually agreed upon
time.

  2.     Buyer’s Representations and Warranties. The
Buyer represents and warrants to the Company that:

 a.      Investment Purpose. As of the date
  hereof, the Buyer is purchasing the Note and the shares of Common Stock issuable
  upon conversion of or otherwise pursuant to the Note, such shares of Common
  Stock being collectively referred to herein as the “Conversion Shares” and,
  collectively with the Note, the “Securities”) for its own account and not with a
  present view towards the public sale or distribution thereof, except pursuant to
  sales registered or exempted from registration under the 1933 Act;
  provided, however, that by making the representations herein, the
  Buyer does not agree to hold any of the Securities for any minimum or other
  specific term and reserves the right to dispose of the Securities at any time in
  accordance with or pursuant to a registration statement or an exemption under
the 1933 Act.

 b.     Accredited Investor Status. The Buyer is an
  “accredited investor” as that term is defined in Rule 501(a) of Regulation D (an
“Accredited Investor”).

c.     Reliance on Exemptions. The Buyer understands
  that the Securities are being offered and sold to it in reliance upon specific
  exemptions from the registration requirements of United States federal and state
  securities laws and that the Company is relying upon the truth and accuracy of,
  and the Buyer’s compliance with, the representations, warranties, agreements,
  acknowledgments and understandings of the Buyer set forth herein in order to
  determine the availability of such exemptions and the eligibility of the Buyer
to acquire the Securities.

 d.     Information. The Buyer and its advisors, if
  any, have been, and for so long as the Note remain outstanding will continue to
  be, furnished with all materials relating to the business, finances and
  operations of the Company and materials relating to the offer and sale of the
  Securities which have been requested by the Buyer or its advisors. The Buyer and
  its advisors, if any, have been, and for so long as the Note remain outstanding
  will continue to be, afforded the opportunity to ask questions of the
Company.

2 

Notwithstanding the foregoing, the Company has not disclosed to
the Buyer any material nonpublic information and will not disclose such
information unless such information is disclosed to the public prior to or
promptly following such disclosure to the Buyer. Neither such inquiries nor any
other due diligence investigation conducted by Buyer or any of its advisors or
representatives shall modify, amend or affect Buyer’s right to rely on the
Company’s representations and warranties contained in Section 3 below. The Buyer
understands that its investment in the Securities involves a significant degree
of risk. The Buyer is not aware of any facts that may constitute a breach of any
of the Company's representations and warranties made herein.

 e.     Governmental Review. The Buyer understands
  that no United States federal or state agency or any other government or
  governmental agency has passed upon or made any recommendation or endorsement of
the Securities.

 f.     Transfer or Re-sale. The Buyer understands
  that (i) the sale or re-sale of the Securities has not been and is not being
  registered under the 1933 Act or any applicable state securities laws, and the
  Securities may not be transferred unless (a) the Securities are sold pursuant to
  an effective registration statement under the 1933 Act, (b) the Buyer shall have
  delivered to the Company, at the cost of the Buyer, an opinion of counsel that
  shall be in form, substance and scope customary for opinions of counsel in
  comparable transactions to the effect that the Securities to be sold or
  transferred may be sold or transferred pursuant to an exemption from such
  registration, which opinion shall be accepted by the Company, (c) the Securities
  are sold or transferred to an “affiliate” (as defined in Rule 144 promulgated
  under the 1933 Act (or a successor rule) (“Rule 144”)) of the Buyer who agrees
  to sell or otherwise transfer the Securities only in accordance with this
  Section 2(f) and who is an Accredited Investor, (d) the Securities are sold
  pursuant to Rule 144, or (e) the Securities are sold pursuant to Regulation S
  under the 1933 Act (or a successor rule) (“Regulation S”), and the Buyer shall
  have delivered to the Company, at the cost of the Buyer, an opinion of counsel
  that shall be in form, substance and scope customary for opinions of counsel in
  corporate transactions, which opinion shall be accepted by the Company; (ii) any
  sale of such Securities made in reliance on Rule 144 may be made only in
  accordance with the terms of said Rule and further, if said Rule is not
  applicable, any re-sale of such Securities under circumstances in which the
  seller (or the person through whom the sale is made) may be deemed to be an
  underwriter (as that term is defined in the 1933 Act) may require compliance
  with some other exemption under the 1933 Act or the rules and regulations of the
  SEC thereunder; and (iii) neither the Company nor any other person is under any
  obligation to register such Securities under the 1933 Act or any state
  securities laws or to comply with the terms and conditions of any exemption
  thereunder (in each case). Notwithstanding the foregoing or anything else
  contained herein to the contrary, the Securities may be pledged as collateral in
  connection with a bona fide margin account or other lending
arrangement.

 g.     Legends. The Buyer understands that the Note
  and, until such time as the Conversion Shares have been registered under the
  1933 Act may be sold pursuant to Rule 144 or Regulation S without any
restriction as to the number of securities as of a particular date that can then be immediately sold, the
Conversion Shares may bear a restrictive legend in substantially the following
form (and a stop-transfer order may be placed against transfer of the
certificates for such Securities):

3 

  	
      “NEITHER THE ISSUANCE AND SALE OF THE SECURITIES
      REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH
      THESE SECURITIES ARE EXERCISABLE HAVE BEEN REGISTERED UNDER THE
      SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES
      LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD,
      TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE
      REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT
      OF 1933, AS AMENDED, OR (B) AN OPINION OF COUNSEL (WHICH COUNSEL
      SHALL BE SELECTED BY THE HOLDER), IN A GENERALLY ACCEPTABLE FORM,
      THAT REGISTRATION IS NOT REQUIRED UNDER SAID ACT OR (II)
      UNLESS SOLD PURSUANT TO RULE 144 OR RULE 144A UNDER SAID
      ACT. NOTWITHSTANDING THE FOREGOING, THE SECURITIES MAY BE
      PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN
      OR FINANCING ARRANGEMENT SECURED BY THE SECURITIES.”

The legend set forth above shall be removed and the Company
shall issue a certificate without such legend to the holder of any Security upon
which it is stamped, if, unless otherwise required by applicable state
securities laws, (a) such Security is registered for sale under an effective
registration statement filed under the 1933 Act or otherwise may be sold
pursuant to Rule 144 or Regulation S without any restriction as to the number of
securities as of a particular date that can then be immediately sold, or (b)
such holder provides the Company with an opinion of counsel, in form, substance
and scope customary for opinions of counsel in comparable transactions, to the
effect that a public sale or transfer of such Security may be made without
registration under the 1933 Act, which opinion shall be accepted by the Company
so that the sale or transfer is effected. The Buyer agrees to sell all
Securities, including those represented by a certificate(s) from which the
legend has been removed, in compliance with applicable prospectus delivery
requirements, if any. In the event that the Company does not accept the opinion
of counsel provided by the Buyer with respect to the transfer of Securities
pursuant to an exemption from registration, such as Rule 144 or Regulation S,
within 2 business days, it will be considered an Event of Default under the
Note.

 h.     Authorization; Enforcement. This Agreement has
  been duly and validly authorized. This Agreement has been duly executed and
  delivered on behalf of the Buyer, and this Agreement constitutes a valid and
binding agreement of the Buyer enforceable in accordance with its terms.

 i.     Residency. The Buyer is a resident of the
  jurisdiction set forth immediately below the Buyer’s name on the signature pages
hereto.

4 

3.     Representations and Warranties of the Company.
The Company represents and warrants to the Buyer that:

 a.     Organization and Qualification. The Company
  and each of its subsidiaries, if any, is a corporation duly organized, validly
  existing and in good standing under the laws of the jurisdiction in which it is
  incorporated, with full power and authority (corporate and other) to own, lease,
  use and operate its properties and to carry on its business as and where now
owned, leased, used, operated and conducted.

 b.     Authorization; Enforcement. (i) The Company
  has all requisite corporate power and authority to enter into and perform this
  Agreement, the Note and to consummate the transactions contemplated hereby and
  thereby and to issue the Securities, in accordance with the terms hereof and
  thereof, (ii) the execution and delivery of this Agreement, the Note by the
  Company and the consummation by it of the transactions contemplated hereby and
  thereby (including without limitation, the issuance of the Note and the issuance
  and reservation for issuance of the Conversion Shares issuable upon conversion
  or exercise thereof) have been duly authorized by the Company’s Board of
  Directors and no further consent or authorization of the Company, its Board of
  Directors, or its shareholders is required, (iii) this Agreement has been duly
  executed and delivered by the Company by its authorized representative, and such
  authorized representative is the true and official representative with authority
  to sign this Agreement and the other documents executed in connection herewith
  and bind the Company accordingly, and (iv) this Agreement constitutes, and upon
  execution and delivery by the Company of the Note, each of such instruments will
  constitute, a legal, valid and binding obligation of the Company enforceable
against the Company in accordance with its terms.

 c.     Issuance of Shares. The Conversion Shares are
  duly authorized and reserved for issuance and, upon conversion of the Note in
  accordance with its respective terms, will be validly issued, fully paid and
  non-assessable, and free from all taxes, liens, claims and encumbrances with
  respect to the issue thereof and shall not be subject to preemptive rights or
  other similar rights of shareholders of the Company and will not impose personal
liability upon the holder thereof.

 d.     Acknowledgment of Dilution. The Company
  understands and acknowledges the potentially dilutive effect to the Common Stock
  upon the issuance of the Conversion Shares upon conversion of the Note. The
  Company further acknowledges that its obligation to issue Conversion Shares upon
  conversion of the Note in accordance with this Agreement, the Note is absolute
  and unconditional regardless of the dilutive effect that such issuance may have
on the ownership interests of other shareholders of the Company.

 e.     No Conflicts. The execution, delivery and
  performance of this Agreement, the Note by the Company and the consummation by
  the Company of the transactions contemplated hereby and thereby (including,
without limitation, the issuance and reservation for issuance of the Conversion Shares) will not
(i) conflict with or result in a violation of any provision of the Certificate
of Incorporation or By-laws, or (ii) violate or conflict with, or result in a
breach of any provision of, or constitute a default (or an event which with
notice or lapse of time or both could become a default) under, or give to others
any rights of termination, amendment, acceleration or cancellation of, any
agreement, indenture, patent, patent license or instrument to which the Company
or any of its subsidiaries is a party, or (iii) result in a violation of any
law, rule, regulation, order, judgment or decree (including federal and state
securities laws and regulations and regulations of any self-regulatory
organizations to which the Company or its securities are subject) applicable to
the Company or any of its subsidiaries or by which any property or asset of the
Company or any of its subsidiaries is bound or affected (except for such
conflicts, defaults, terminations, amendments, accelerations, cancellations and
violations as would not, individually or in the aggregate, have a material
adverse effect). All consents, authorizations, orders, filings and registrations
which the Company is required to obtain pursuant to the preceding sentence have
been obtained or effected on or prior to the date hereof. The Company is not in
violation of the listing requirements of the Over-the-Counter Quotations Bureau
(the “OTCQB”) and does not reasonably anticipate that the Common Stock will be
delisted by the OTCQB in the foreseeable future, nor are the Company’s
securities “chilled” by FINRA. The Company and its subsidiaries are unaware of
any facts or circumstances, which might give rise to any of the foregoing.

5 

 f.     Absence of Litigation. Except as disclosed in
  the Company’s public filings, there is no action, suit, claim, proceeding,
  inquiry or investigation before or by any court, public board, government
  agency, self-regulatory organization or body pending or, to the knowledge of the
  Company or any of its subsidiaries, threatened against or affecting the Company
  or any of its subsidiaries, or their officers or directors in their capacity as
  such, that could have a material adverse effect. Schedule 3(f) contains a
  complete list and summary description of any pending or, to the knowledge of the
  Company, threatened proceeding against or affecting the Company or any of its
  subsidiaries, without regard to whether it would have a material adverse effect.
  The Company and its subsidiaries are unaware of any facts or circumstances,
which might give rise to any of the foregoing.

 g.     Acknowledgment Regarding Buyer’ Purchase of
    Securities. The Company acknowledges and agrees that the Buyer is acting
  solely in the capacity of arm’s length purchasers with respect to this Agreement
  and the transactions contemplated hereby. The Company further acknowledges that
  the Buyer is not acting as a financial advisor or fiduciary of the Company (or
  in any similar capacity) with respect to this Agreement and the transactions
  contemplated hereby and any statement made by the Buyer or any of its respective
  representatives or agents in connection with this Agreement and the transactions
  contemplated hereby is not advice or a recommendation and is merely incidental
  to the Buyer’ purchase of the Securities. The Company further represents to the
  Buyer that the Company’s decision to enter into this Agreement has been based
  solely on the independent evaluation of the Company and its representatives.

6 

 h.     No Integrated Offering. Neither the Company,
nor any of its affiliates, nor any person acting on its or their behalf, has
directly or indirectly made any offers or sales in any security or solicited any
offers to buy any security under circumstances that would require registration
under the 1933 Act of the issuance of the Securities to the Buyer. The issuance
of the Securities to the Buyer will not be integrated with any other issuance of
the Company’s securities (past, current or future) for purposes of any
shareholder approval provisions applicable to the Company or its securities.

 i.     Title to Property. The Company and its
  subsidiaries have good and marketable title in fee simple to all real property
  and good and marketable title to all personal property owned by them which is
  material to the business of the Company and its subsidiaries, in each case free
  and clear of all liens, encumbrances and defects except such as are described in
  Schedule 3(i) or such as would not have a material adverse effect. Any real
  property and facilities held under lease by the Company and its subsidiaries are
  held by them under valid, subsisting and enforceable leases with such exceptions
as would not have a material adverse effect.

 j.     Bad Actor. No officer or director of the
  Company would be disqualified under Rule 506(d) of the Securities Act as amended
  on the basis of being a "bad actor" as that term is established in the September
  19, 2013 Small Entity Compliance Guide published by the Securities and Exchange
Commission.

 k.     Breach of Representations and Warranties by the
    Company. If the Company breaches any of the representations or warranties
  set forth in this Section 3, and in addition to any other remedies available to
  the Buyer pursuant to this Agreement, it will be considered an Event of default
under the Note.

4.     COVENANTS.

 a.     Listing. The Company shall promptly secure the
  listing of the Conversion Shares upon each national securities exchange or
  automated quotation system, if any, upon which shares of Common Stock are then
  listed (subject to official notice of issuance) and, so long as the Buyer owns
  any of the Securities, shall maintain, so long as any other shares of Common
  Stock shall be so listed, such listing of all Conversion Shares from time to
  time issuable upon conversion of the Note. The Company will obtain and, so long
  as the Buyer owns any of the Securities, maintain the listing and trading of its
  Common Stock on the OTCQB, OTC Pink, or any equivalent replacement exchange, the
  Nasdaq National Market (“Nasdaq”), the Nasdaq SmallCap Market (“Nasdaq
  SmallCap”), the New York Stock Exchange (“NYSE”), or the American Stock Exchange
  (“AMEX”) and will comply in all respects with the Company’s reporting, filing
  and other obligations under the bylaws or rules of the Financial Industry
  Regulatory Authority (“FINRA”) and such exchanges, as applicable. The Company
shall promptly provide to the Buyer copies of any notices it receives from the OTCQB, OTC Pink, and any other
exchanges or quotation systems on which the Common Stock is then listed
regarding the continued eligibility of the Common Stock for listing on such
exchanges and quotation systems.

7 

 b.     Corporate Existence. So long as the Buyer
  beneficially owns any Note, the Company shall maintain its corporate existence
  and shall not sell all or substantially all of the Company’s assets, except in
  the event of a merger or consolidation or sale of all or substantially all of
  the Company’s assets, where the surviving or successor entity in such
  transaction (i) assumes the Company’s obligations hereunder and under the
  agreements and instruments entered into in connection herewith and (ii) is a
  publicly traded corporation whose Common Stock is listed for trading on the OTC
Pink, OTCQB, Nasdaq, Nasdaq SmallCap, NYSE or AMEX.

 c.     No Integration. The Company shall not make any
  offers or sales of any security (other than the Securities) under circumstances
  that would require registration of the Securities being offered or sold
  hereunder under the 1933 Act or cause the offering of the Securities to be
  integrated with any other offering of securities by the Company for the purpose
  of any stockholder approval provision applicable to the Company or its
securities.

 d.     Registration Rights. With respect to any
  Company issued note owned by the Buyer, in the event the Company completes a
  registration statement for its securities prior to the date on which that
  particular note is eligible for conversion into legend free shares under Rule
  144, the shares issuable upon conversion of that particular note shall be
“piggybacked” onto the registration statement.

 e.     Breach of Covenants. If the Company breaches
  any of the covenants set forth in this Section 4, and in addition to any other
  remedies available to the Buyer pursuant to this Agreement, it will be
considered an event of default under the Note.

5.     Governing Law; Miscellaneous.

 a.     Governing Law. This Agreement shall be
  governed by and construed in accordance with the laws of the State of New York
  without regard to principles of conflicts of laws. Any action brought by either
  party against the other concerning the transactions contemplated by this
  Agreement shall be brought only in the state courts of New York or in the
  federal courts located in the state and county of New York. The parties to this
  Agreement hereby irrevocably waive any objection to jurisdiction and venue of
  any action instituted hereunder and shall not assert any defense based on lack
  of jurisdiction or venue or based upon forum non conveniens. The Company
  and Buyer waive trial by jury. The prevailing party shall be entitled to recover
  from the other party its reasonable attorney's fees and costs. In the event that
  any provision of this Agreement or any other agreement delivered in connection
herewith is invalid or unenforceable under any applicable statute or rule of law, then such provision
shall be deemed inoperative to the extent that it may conflict therewith and
shall be deemed modified to conform with such statute or rule of law. Any such
provision, which may prove invalid or unenforceable under any law, shall not
affect the validity or enforceability of any other provision of any agreement.
Each party hereby irrevocably waives personal service of process and consents to
process being served in any suit, action or proceeding in connection with this
Agreement or any other Transaction Document by mailing a copy thereof via
registered or certified mail or overnight delivery (with evidence of delivery)
to such party at the address in effect for notices to it under this Agreement
and agrees that such service shall constitute good and sufficient service of
process and notice thereof. Nothing contained herein shall be deemed to limit in
any way any right to serve process in any other manner permitted by law.

8 

 b.     Counterparts; Signatures by Facsimile. This
  Agreement may be executed in one or more counterparts, each of which shall be
  deemed an original but all of which shall constitute one and the same agreement
  and shall become effective when counterparts have been signed by each party and
  delivered to the other party. This Agreement, once executed by a party, may be
  delivered to the other party hereto by facsimile transmission of a copy of this
Agreement bearing the signature of the party so delivering this Agreement.

 c.     Headings. The headings of this Agreement are
  for convenience of reference only and shall not form part of, or affect the
interpretation of, this Agreement.

 d.     Severability. In the event that any provision
  of this Agreement is invalid or unenforceable under any applicable statute or
  rule of law, then such provision shall be deemed inoperative to the extent that
  it may conflict therewith and shall be deemed modified to conform with such
  statute or rule of law. Any provision hereof which may prove invalid or
  unenforceable under any law shall not affect the validity or enforceability of
any other provision hereof.

 e.     Entire Agreement; Amendments. This Agreement
  and the instruments referenced herein contain the entire understanding of the
  parties with respect to the matters covered herein and therein and, except as
  specifically set forth herein or therein, neither the Company nor the Buyer
  makes any representation, warranty, covenant or undertaking with respect to such
  matters. No provision of this Agreement may be waived or amended other than by
an instrument in writing signed by the majority in interest of the Buyer.

f.     Notices. All notices, demands, requests,
  consents, approvals, and other communications required or permitted hereunder
  shall be in writing and, unless otherwise specified herein, shall be (i)
  personally served, (ii) deposited in the mail, registered or certified, return
  receipt requested, postage prepaid, (iii) delivered by reputable air courier
  service with charges prepaid, or (iv) transmitted by hand delivery, telegram, or
  facsimile, addressed as set forth below or to such other address as such party
shall have specified most recently by written notice. Any
notice or other communication required or permitted to be given hereunder shall
be deemed effective (a) upon hand delivery or delivery by facsimile, with
accurate confirmation generated by the transmitting facsimile machine, at the
address or number designated below (if delivered on a business day during normal
business hours where such notice is to be received), or the first business day
following such delivery (if delivered other than on a business day during normal
business hours where such notice is to be received) or (b) on the second
business day following the date of mailing by express courier service, fully
prepaid, addressed to such address, or upon actual receipt of such mailing,
whichever shall first occur. The addresses for such communications shall be:

9 

	 	If to the Company, to: 
	 	  
	 	         Lithium
      Exploration Group, Inc. 
	 	         3800 North
      Central Avenue, Suite 820 
	 	         Phoenix, AZ
      85012 
	 	         Attn: Alex
      Walsh- CEO 
	 	  
	 	  
	 	If to the Buyer: 
	 	  
	 	         BlueCiti, LLC
    
	 	         1357 Ave
      Ashford, 
	 	         San Juan, PR
      00907 
	 	         Attn: Manager

 Each party
shall provide notice to the other party of any change in address. 

g.     Successors and Assigns. This Agreement shall
be binding upon and inure to the benefit of the parties and their successors and
assigns. Neither the Company nor the Buyer shall assign this Agreement or any
rights or obligations hereunder without the prior written consent of the other.
Notwithstanding the foregoing, the Buyer may assign its rights hereunder to any
person that purchases Securities in a private transaction from the Buyer or to
any of its “affiliates,” as that term is defined under the 1934 Act, without the
consent of the Company. 

 h.     Third Party Beneficiaries. This Agreement is
intended for the benefit of the parties hereto and their respective permitted
successors and assigns, and is not for the benefit of, nor may any provision
hereof be enforced by, any other person. 

i.     Survival. The representations and warranties
of the Company and the agreements and covenants set forth in this Agreement
shall survive the closing hereunder notwithstanding any due diligence
investigation conducted by or on behalf of the Buyer. The Company agrees to indemnify and hold harmless
the Buyer and all their officers, directors, employees and agents for loss or
damage arising as a result of or related to any breach or alleged breach by the
Company of any of its representations, warranties and covenants set forth in
this Agreement or any of its covenants and obligations under this Agreement,
including advancement of expenses as they are incurred.

10 

 j.     Further Assurances. Each party shall do and
  perform, or cause to be done and performed, all such further acts and things,
  and shall execute and deliver all such other agreements, certificates,
  instruments and documents, as the other party may reasonably request in order to
  carry out the intent and accomplish the purposes of this Agreement and the
consummation of the transactions contemplated hereby.

 k.     No Strict Construction. The language used in
  this Agreement will be deemed to be the language chosen by the parties to
  express their mutual intent, and no rules of strict construction will be applied
against any party.

 l.     Remedies. The Company acknowledges that a
  breach by it of its obligations hereunder will cause irreparable harm to the
  Buyer by vitiating the intent and purpose of the transaction contemplated
  hereby. Accordingly, the Company acknowledges that the remedy at law for a
  breach of its obligations under this Agreement will be inadequate and agrees, in
  the event of a breach or threatened breach by the Company of the provisions of
  this Agreement, that the Buyer shall be entitled, in addition to all other
  available remedies at law or in equity, and in addition to the penalties
  assessable herein, to an injunction or injunctions restraining, preventing or
  curing any breach of this Agreement and to enforce specifically the terms and
  provisions hereof, without the necessity of showing economic loss and without
any bond or other security being required. 

IN WITNESS WHEREOF, the undersigned Buyer and the Company have
caused this Agreement to be duly executed as of the date first above written.

	Lithium Exploration Group, Inc. 
	  
	  
	By: 		 
	Name: Alex Walsh 
	Title: CEO 

	BlueCiti, LLC. 
	 	 
	By: ______________________________________
	Name:Manager 

11 

	AGGREGATE SUBSCRIPTION AMOUNT: 	  
	 	 
	Aggregate Principal Amount of Note: 	$27,500.00 
	 	 
	$2,500 in OID, attached as Exhibit A, hereto 	  

EXHIBIT A
144 NOTE - $27,500 

12 

13

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00283-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00283-of-00352.parquet"}]]